explore -WSS

explore

author：fashion 2025-10-01 21:34:26 - browse：72

Ethylene Oxide Sterilizer machine. -- health tech coverage from STAT — Ethylene oxide, a chemical used to sterilize half of all medical devices in the U.S., can also cause cancer. 3M via AP

The chemical used to sterilize half of all medical devices in the United States is also known to cause cancer. After years of deliberating on alternatives, the Food and Drug Administration this month deemed a safer gas, vaporized hydrogen peroxide, a legitimate way to decontaminate devices.

It’s a small step in pushing the medical device industry away from the carcinogenic chemical, called ethylene oxide. The move comes as the Environmental Protection Agency prepares to finalize restrictions on ethylene oxide in March. Medical device manufacturers will have 18 months to comply.

Environmental activists organizing against the sterilizing facilities in their communities commend the EPA for curtailing the chemical. But they also want the FDA to more adamantly push device makers toward alternatives, which the FDA’s endorsement does not do.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Hepatitis C has a cure — but many Americans still lack access to it
Next article： 'Essentially witchcraft:' A former naturopath takes on the field

WSS

In boost for rare disease push, AstraZeneca to buy Amolyt Pharma

Heat wave can put hearts into ‘oxygen debt,' lab experiment shows

Cheap, fast test for Zika and dengue could cost just $1

'Essentially witchcraft:' A former naturopath takes on the field

Curing rare childhood diseases will falter unless Congress steps up

'Essentially witchcraft:' A former naturopath takes on the field

entertainment

explore

entertainment

Anesthesiologist group: stop taking Ozempic before surgery

My daughter's legacy lives on through her writing, phage therapy

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

UCLA team creates talking throat patch for voice disorders

BioMarin wins approval for gene therapy to treat hemophilia A

Readout LOUD podcast: ALS dilemma, first MASH drug, and more

BioMarin wins approval for gene therapy to treat hemophilia A

ALS patient reclaims some autonomy thanks to wearable 'robot'

Medical leaders decry Supreme Court decision on affirmative action

'Essentially witchcraft:' A former naturopath takes on the field

hotspot

FDA advisers back CAR

Teladoc has a new CEO, but challenges remain the same

Medical device trials still don't enroll enough women, study finds

FDA advisers back CAR

Teladoc has a new CEO, but challenges remain the same

Readout Newsletter: CAR

leisure time

entertainment

leisure time

leisure time